Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian
GET TICKETS

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades

Analysts at Jefferies upgraded Finisar (NASDAQ: FNSR) from “underperform” to “hold.” The target price for Finisar has been raised from $11.50 to $22.50. Finisar's shares closed at $23.54 yesterday.

Stifel Nicolaus upgraded Cloud Peak Energy (NYSE: CLD) from “hold” to “buy.” Cloud Peak Energy's shares closed at $14.57 yesterday.

Analysts at Goldman Sachs upgraded Tenet Healthcare (NYSE: THC) from “neutral” to “buy.” The target price for Tenet Healthcare has been raised from $47 to $55. Tenet Healthcare's shares closed at $46.10 yesterday.

Analysts at Morgan Stanley upgraded ABB (NYSE: ABB) from “underweight” to “equal-weight.” ABB's shares closed at $23.24 yesterday.

Latest Ratings for FNSR

DateFirmActionFromTo
Dec 2018DowngradesBuyHold
Dec 2018DowngradesBuyNeutral
Dec 2018MaintainsEqual-WeightEqual-Weight

View More Analyst Ratings for FNSR
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (ABB + CLD)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
PSTGMaintains21.0
DCODowngrades
DYMaintains63.0
PSTGMaintains26.0
URBNMaintains28.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Alnylam Pharma Announces Advancement of Development Candidate for ALN-AS1

Benzinga's Top Initiations